Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD)

A. Hadchouel Duvergé, F. Decobert, I. Layouni, P. H. Jarreau, R. Lenclen, M. L. Franco-Montoya, J. Bourbon, C. Delacourt (Créteil, Paris, Poissy, France)

Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session: Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session type: E-Communication Session
Number: 3550
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Hadchouel Duvergé, F. Decobert, I. Layouni, P. H. Jarreau, R. Lenclen, M. L. Franco-Montoya, J. Bourbon, C. Delacourt (Créteil, Paris, Poissy, France). Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD). Eur Respir J 2010; 36: Suppl. 54, 3550

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010

Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010

The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006

Matrix metalloproteinase (MMP) -1 and -3 promoter polymorphisms in Bulgarian patients with COPD
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011


Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004

Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip
Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Year: 2007


Effects of glutation-S-transferase M1 (GSTM1) and T1 (GSTT1) and matrix metalloproteinase 9 (MMP9) on the decline of lung function in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004

Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

Matrix metalloproteinase 2 expression in distal lung of fatal asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 549s
Year: 2006

Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008


A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018


Activity of matrix metalloproteinases and their inhibitor in children with bronchopulmonary dysplasia
Source: Annual Congress 2009 - Respiratory physiology in infants and preschool children, in health and disease
Year: 2009

Quantitative assessment of matrix metalloproteinasis 7 (MMP-7) and tissue inhibitor of MMP-7 (TIMP1) in NSCLC tissue samples
Source: Eur Respir J 2006; 28: Suppl. 50, 813s
Year: 2006

The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Temporal analysis of macrophage infiltration, expression of metalloproteinase 12 and isoprostane-8 in an experimental model of emphysema
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010


-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010


Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008

Polymorphism of multidrug resistance gene (MDR1), interleukin 4 (IL4), IL13 genes in asthmatic patients and patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010